Actively Recruiting

Age: 18Years - 99Years
All Genders
NCT05553873

Evaluation of Inflammatory Markers in ph Negative Myeloproliferative Neoplasms: Impact on Outcome and Response to Therapy. Multicenter Retro-prospective Observational Study. The INFLA-ME (INFLAmmation in Myeloproliferative Disease) Study.

Led by University of Milano Bicocca · Updated on 2024-01-02

500

Participants Needed

11

Research Sites

220 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

This study aims to observe inflammatory biomarkers and their trend over the history of the disease in patients suffering from MPN Ph negative; it also wants to identify any correlations between the aforementioned biomarkers and disease outcomes, considering first of all the occurrence of thrombo-haemorrhagic events and the evolution in the accelerated / blast phase of the disease, shedding light on new tools that can potentially guarantee a prompt and better risk stratification

CONDITIONS

Official Title

Evaluation of Inflammatory Markers in ph Negative Myeloproliferative Neoplasms: Impact on Outcome and Response to Therapy. Multicenter Retro-prospective Observational Study. The INFLA-ME (INFLAmmation in Myeloproliferative Disease) Study.

Who Can Participate

Age: 18Years - 99Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Age 18 years or older at diagnosis of Philadelphia chromosome-negative MPN
  • Diagnosis of polycythemia vera, essential thrombocythemia, primary myelofibrosis, or post-polycythemia vera and post-essential thrombocythemia myelofibrosis since 2000 according to WHO or IWG-MRT criteria
  • Signed informed consent to participate in the study
Not Eligible

You will not qualify if you...

  • Life expectancy less than 6 months
  • Accelerated phase myelofibrosis or MPN with signs of leukemic transformation

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 11 locations

1

Azienda Ospedaliera Universitaria Consorziale Policlinico

Bari, Italy

Actively Recruiting

2

Policlinico Sant'Orsola Malpighi

Bologna, Italy

Actively Recruiting

3

ASST Spedali Civili di Brescia

Brescia, Italy

Actively Recruiting

4

Policlinico Vittorio Emanuele

Catania, Italy

Actively Recruiting

5

Ospedale Universitario Federico II

Naples, Italy

Actively Recruiting

6

Policlinico Umberto I, Università La Sapienza

Roma, Italy

Actively Recruiting

7

Azienda Ospedaliera Universitaria Città della Salute e delle Scienza

Torino, Italy

Actively Recruiting

8

Ospedale San Luigi di Orbassano - Ospedale Mauriziano

Torino, Italy

Actively Recruiting

9

Azienda Ospedaliera Universitaria Friuli Centrale

Udine, Italy

Actively Recruiting

10

Azienda Ospedaliera Universitaria Integrata

Verona, Italy

Actively Recruiting

11

Ospedale Belcolle

Viterbo, Italy

Actively Recruiting

Loading map...

Research Team

E

Elena Maria Elli

CONTACT

B

Benedetta Valeri

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

0

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Evaluation of Inflammatory Markers in ph Negative Myeloproliferative Neoplasms: Impact on Outcome and Response to Therapy. Multicenter Retro-prospective Observational Study. The INFLA-ME (INFLAmmation in Myeloproliferative Disease) Study. | DecenTrialz